12/2014. Clustoid Study
It has been published in the journal Allergy a clinical trial, randomized double-blind, placebo-controlled study, performed in Germany with CLUSTOID.
Title: A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol
Authors: Klimek L, Uhlig J, Mösges R, Rettig K, Pfaar O.
Center for Rhinology and Allergology, Wiesbaden; Germany
Roxall Medizin, Hamburg; Germany
IMSIE, University of Cologne, Cologne; Germany
GEM, Bureau of Evaluation & Quality Assurance in Medicine GmbH, Meerbusch, Germany
CLUSTOID is an allergy vaccine containing glutaraldehyde-polymerized allergens. CLUSTOID is manufactured by INMUNOTEK and marketed in Germany by Roxall Medizin GmbH. In other countries is also marketed as CLUSTOID (Spain, Austria and Italy), or as CLUSTEK or ALXOID. This is the second paper on the clinical efficacy of CLUSTOID. See the first one